Flame Retardant Toxicity Testing Will Not Be Required by EPA

Federal environmental regulators have decided not to require manufacturers of three commonly used flame retardants to conduct toxicity tests, rejecting a petition filed by a consumer group that highlighted the potential risks the chemicals may pose to humans and the environment. 

The U.S. Environmental Protection Agency (EPA) issued a prepublication copy of a decision (PDF) on April 6, which announced that the agency will not require toxicity or exposure tests on chlorinated tris flame retardants, which are used to manufacture foam for furniture, paint and textiles. The exempted group of three flame retardants are known as chlorinated phosphate ester (CPE) cluster chemicals.

An environmental coalition, headed by Earthjustice and five other environmental groups, filed a petition January 6, calling on the EPA to force manufacturers to conduct the safety testing, warning that the chemicals may pose unreasonable side effects.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Past studies have linked various categories of flame retardants to side effects ranging from increased risk of thyroid cancer and increased risk of preterm birth.

The EPA said the petition did not provide enough evidence to support a ban on the flame retardants. The agency reviewed data from scientific studies, conclusions reached by the state of California and the European Union, as well as preliminary assessment information released by the EPA in August 2015.

The decision indicates the EPA also used computer modeling and other analytical approaches to evaluate the safety and effects to the environment posed by the flame retardants.

In 2014, California enacted new regulations focusing on flame retardants. The rules allowed furniture manufactures to use other means, aside from toxic flame retardants, to ensure furniture meets flammability requirements. Many hoped the rest of the country would follow suit, as manufacturers focused on meeting California manufacturing standards.

While the EPA left the possibility open in its recent ruling that it could review more data in the future, it ruled the current data was not enough to determine the chemicals posed a risk to human health or the environment. The agency also did not make a determination on whether the chemicals mimic, alter or block hormone functions.

A study published earlier this year indicated that more than 90% of adults and children in the U.S. have high levels of flame retardant chemicals in the bodies. Those chemicals include the controversial chlorinated tris the environmental coalition urged the EPA to rule against.

Another study indicated high levels of flame retardants are also found in household dust throughout most homes across the country.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

More than 2,000 Depo-Provera brain tumor lawsuits have been filed in state and federal courts nationwide, according to recent court documents, with potentially thousands more claims pending.
A federal judge will meet with lead counsel in the Suboxone litigation tomorrow to receive an update on the number of Suboxone lawsuits filed and the status of discovery.